These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19436109)

  • 81. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling.
    Mateo M; Reid SP; Leung LW; Basler CF; Volchkov VE
    J Virol; 2010 Jan; 84(2):1169-75. PubMed ID: 19889762
    [TBL] [Abstract][Full Text] [Related]  

  • 82. IFN-beta-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9.
    Laver T; Nozell SE; Benveniste EN
    J Interferon Cytokine Res; 2008 Jan; 28(1):13-23. PubMed ID: 18370868
    [TBL] [Abstract][Full Text] [Related]  

  • 83. IFNα converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets.
    Bachmann M; Ulziibat S; Härdle L; Pfeilschifter J; Mühl H
    Biochem Pharmacol; 2013 Feb; 85(3):396-403. PubMed ID: 23153456
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.
    Ogishi M; Arias AA; Yang R; Han JE; Zhang P; Rinchai D; Halpern J; Mulwa J; Keating N; Chrabieh M; Lainé C; Seeleuthner Y; Ramírez-Alejo N; Nekooie-Marnany N; Guennoun A; Muller-Fleckenstein I; Fleckenstein B; Kilic SS; Minegishi Y; Ehl S; Kaiser-Labusch P; Kendir-Demirkol Y; Rozenberg F; Errami A; Zhang SY; Zhang Q; Bohlen J; Philippot Q; Puel A; Jouanguy E; Pourmoghaddas Z; Bakhtiar S; Willasch AM; Horneff G; Llanora G; Shek LP; Chai LYA; Tay SH; Rahimi HH; Mahdaviani SA; Nepesov S; Bousfiha AA; Erdeniz EH; Karbuz A; Marr N; Navarrete C; Adeli M; Hammarstrom L; Abolhassani H; Parvaneh N; Al Muhsen S; Alosaimi MF; Alsohime F; Nourizadeh M; Moin M; Arnaout R; Alshareef S; El-Baghdadi J; Genel F; Sherkat R; Kiykim A; Yücel E; Keles S; Bustamante J; Abel L; Casanova JL; Boisson-Dupuis S
    J Exp Med; 2022 Oct; 219(10):. PubMed ID: 36094518
    [TBL] [Abstract][Full Text] [Related]  

  • 85. MSMD in a 3-Generation Multiplex Kindred Due to Autosomal Dominant STAT1 Deficiency.
    Bhattad S; Unni J; Varkey S
    J Clin Immunol; 2021 Jan; 41(1):259-261. PubMed ID: 33064256
    [No Abstract]   [Full Text] [Related]  

  • 86. Inherited STAT1 Deficiency in a Child with BCG-osis and Severe COVID-19 Pneumonia.
    Guèye MS; Ndiaye-Diop MT; ; Bustamante J; Dièye TN
    J Clin Immunol; 2023 Oct; 43(7):1479-1482. PubMed ID: 37258985
    [No Abstract]   [Full Text] [Related]  

  • 87. Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
    Yamazaki Y; Yamada M; Kawai T; Morio T; Onodera M; Ueki M; Watanabe N; Takada H; Takezaki S; Chida N; Kobayashi I; Ariga T
    J Immunol; 2014 Nov; 193(10):4880-7. PubMed ID: 25288569
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation.
    Vairo D; Tassone L; Tabellini G; Tamassia N; Gasperini S; Bazzoni F; Plebani A; Porta F; Notarangelo LD; Parolini S; Giliani S; Badolato R
    Blood; 2011 Aug; 118(7):1806-17. PubMed ID: 21772053
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
    Liu L; Okada S; Kong XF; Kreins AY; Cypowyj S; Abhyankar A; Toubiana J; Itan Y; Audry M; Nitschke P; Masson C; Toth B; Flatot J; Migaud M; Chrabieh M; Kochetkov T; Bolze A; Borghesi A; Toulon A; Hiller J; Eyerich S; Eyerich K; Gulácsy V; Chernyshova L; Chernyshov V; Bondarenko A; Grimaldo RM; Blancas-Galicia L; Beas IM; Roesler J; Magdorf K; Engelhard D; Thumerelle C; Burgel PR; Hoernes M; Drexel B; Seger R; Kusuma T; Jansson AF; Sawalle-Belohradsky J; Belohradsky B; Jouanguy E; Bustamante J; Bué M; Karin N; Wildbaum G; Bodemer C; Lortholary O; Fischer A; Blanche S; Al-Muhsen S; Reichenbach J; Kobayashi M; Rosales FE; Lozano CT; Kilic SS; Oleastro M; Etzioni A; Traidl-Hoffmann C; Renner ED; Abel L; Picard C; Maródi L; Boisson-Dupuis S; Puel A; Casanova JL
    J Exp Med; 2011 Aug; 208(8):1635-48. PubMed ID: 21727188
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A novel form of human STAT1 deficiency impairing early but not late responses to interferons.
    Kong XF; Ciancanelli M; Al-Hajjar S; Alsina L; Zumwalt T; Bustamante J; Feinberg J; Audry M; Prando C; Bryant V; Kreins A; Bogunovic D; Halwani R; Zhang XX; Abel L; Chaussabel D; Al-Muhsen S; Casanova JL; Boisson-Dupuis S
    Blood; 2010 Dec; 116(26):5895-906. PubMed ID: 20841510
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A heterozygous dominant-negative mutation in the coiled-coil domain of STAT1 is the cause of autosomal-dominant Mendelian susceptibility to mycobacterial diseases.
    Ueki M; Yamada M; Ito K; Tozawa Y; Morino S; Horikoshi Y; Takada H; Abdrabou SS; Takezaki S; Kobayashi I; Ariga T
    Clin Immunol; 2017 Jan; 174():24-31. PubMed ID: 27856304
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human T-bet Governs Innate and Innate-like Adaptive IFN-γ Immunity against Mycobacteria.
    Yang R; Mele F; Worley L; Langlais D; Rosain J; Benhsaien I; Elarabi H; Croft CA; Doisne JM; Zhang P; Weisshaar M; Jarrossay D; Latorre D; Shen Y; Han J; Ogishi M; Gruber C; Markle J; Al Ali F; Rahman M; Khan T; Seeleuthner Y; Kerner G; Husquin LT; Maclsaac JL; Jeljeli M; Errami A; Ailal F; Kobor MS; Oleaga-Quintas C; Roynard M; Bourgey M; El Baghdadi J; Boisson-Dupuis S; Puel A; Batteux F; Rozenberg F; Marr N; Pan-Hammarström Q; Bogunovic D; Quintana-Murci L; Carroll T; Ma CS; Abel L; Bousfiha A; Di Santo JP; Glimcher LH; Gros P; Tangye SG; Sallusto F; Bustamante J; Casanova JL
    Cell; 2020 Dec; 183(7):1826-1847.e31. PubMed ID: 33296702
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.
    Kagawa R; Fujiki R; Tsumura M; Sakata S; Nishimura S; Itan Y; Kong XF; Kato Z; Ohnishi H; Hirata O; Saito S; Ikeda M; El Baghdadi J; Bousfiha A; Fujiwara K; Oleastro M; Yancoski J; Perez L; Danielian S; Ailal F; Takada H; Hara T; Puel A; Boisson-Dupuis S; Bustamante J; Casanova JL; Ohara O; Okada S; Kobayashi M
    J Allergy Clin Immunol; 2017 Jul; 140(1):232-241. PubMed ID: 28011069
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Novel STAT1 alleles in a patient with impaired resistance to mycobacteria.
    Kristensen IA; Veirum JE; Møller BK; Christiansen M
    J Clin Immunol; 2011 Apr; 31(2):265-71. PubMed ID: 21057861
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Herpes simplex encephalitis in a patient with a distinctive form of inherited IFNAR1 deficiency.
    Bastard P; Manry J; Chen J; Rosain J; Seeleuthner Y; AbuZaitun O; Lorenzo L; Khan T; Hasek M; Hernandez N; Bigio B; Zhang P; Lévy R; Shrot S; Reino EJG; Lee YS; Boucherit S; Aubart M; Gijsbers R; Béziat V; Li Z; Pellegrini S; Rozenberg F; Marr N; Meyts I; Boisson B; Cobat A; Bustamante J; Zhang Q; Jouangy E; Abel L; Somech R; Casanova JL; Zhang SY
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32960813
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines.
    Hernandez N; Bucciol G; Moens L; Le Pen J; Shahrooei M; Goudouris E; Shirkani A; Changi-Ashtiani M; Rokni-Zadeh H; Sayar EH; Reisli I; Lefevre-Utile A; Zijlmans D; Jurado A; Pholien R; Drutman S; Belkaya S; Cobat A; Boudewijns R; Jochmans D; Neyts J; Seeleuthner Y; Lorenzo-Diaz L; Enemchukwu C; Tietjen I; Hoffmann HH; Momenilandi M; Pöyhönen L; Siqueira MM; de Lima SMB; de Souza Matos DC; Homma A; Maia MLS; da Costa Barros TA; de Oliveira PMN; Mesquita EC; Gijsbers R; Zhang SY; Seligman SJ; Abel L; Hertzog P; Marr N; Martins RM; Meyts I; Zhang Q; MacDonald MR; Rice CM; Casanova JL; Jouanguy E; Bossuyt X
    J Exp Med; 2019 Sep; 216(9):2057-2070. PubMed ID: 31270247
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis.
    Hirata O; Okada S; Tsumura M; Kagawa R; Miki M; Kawaguchi H; Nakamura K; Boisson-Dupuis S; Casanova JL; Takihara Y; Kobayashi M
    Haematologica; 2013 Oct; 98(10):1641-9. PubMed ID: 23585529
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Dominant-negative STAT1 SH2 domain mutations in unrelated patients with Mendelian susceptibility to mycobacterial disease.
    Tsumura M; Okada S; Sakai H; Yasunaga S; Ohtsubo M; Murata T; Obata H; Yasumi T; Kong XF; Abhyankar A; Heike T; Nakahata T; Nishikomori R; Al-Muhsen S; Boisson-Dupuis S; Casanova JL; Alzahrani M; Shehri MA; Elghazali G; Takihara Y; Kobayashi M
    Hum Mutat; 2012 Sep; 33(9):1377-87. PubMed ID: 22573496
    [TBL] [Abstract][Full Text] [Related]  

  • 99. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis.
    van de Veerdonk FL; Plantinga TS; Hoischen A; Smeekens SP; Joosten LA; Gilissen C; Arts P; Rosentul DC; Carmichael AJ; Smits-van der Graaf CA; Kullberg BJ; van der Meer JW; Lilic D; Veltman JA; Netea MG
    N Engl J Med; 2011 Jul; 365(1):54-61. PubMed ID: 21714643
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Diagnosis and Management of Infections in Patients with Mendelian Susceptibility to Mycobacterial Disease.
    Dalvi A; Bargir UA; Natraj G; Shah I; Madkaikar M
    Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.